Athersys Inc
(NASDAQ: ATHX)
-0.02
-1.06%
| Exchange: | NASDAQ |
| Stock: | Athersys Inc |
| Industry: | NA |
| Employees: | 48 |
| Athersys, Inc. is a United States-based company that develops therapeutic products for the treatment of life threatening and other types of diseases. The Company produces therapeutic proteins, validates biological targets for development and conducts screening for gene discovery. Athersys currently has active therapeutic product development programs in the areas of oncology, inflammation and neurobiology, including small molecule development programs and monoclonal antibody programs. The Company has initiated multiple development programs using its proprietary adult stem cell technology in areas such as developmental disorders, immunology, neurobiology, tissue regeneration, metabolic disease and disorders of the endocrine system. |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
